SEARCH

SEARCH BY CITATION

References

  • Akhtar, S. & Benter, I. 2007. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity. Adv. Drug Deliv. Rev. 59, 164182.
  • Banker, B. Q. & Engel, A. G. 2004. Basic reactions of muscle. Myology 1, 691747.
  • Bartlett, G. R. 1959. Colorimetric assay methods for free and phosphorylated glyceric acids. J. Biol. Chem. 234, 469471.
  • Barichello, J. M., Kizuki, S., Tagami, T., Soares, L. A. L., Ishida, T., Kikuchi, H. & Kiwada, H. 2012. Agitation during lipoplex formation harmonizes the interaction of siRNA to cationic liposomes. Int. J. Pharm. 430, 359365.
  • Behlke, M. A. 2006. Progress towards in vivo use of siRNAs. Mol. Ther. 13, 644670.
  • Bottinelli, R., Canepari, M., Pellegrino, M. A. & Reggiani, C. 1996. Force-velocity properties of human skeletal muscle fibres: myosin heavy chain isoform and temperature dependence. J. Physiol. 495, 573586.
  • Eckardt, L. & Harzer, W. 1996. Facial structure and functional findings in patients with progressive muscular dystrophy (Duchenne). Am. J. Orthod. Dentofacial Orthop. 110, 185190.
  • Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K. & Tuschl, T. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494498.
  • Emery, A. E. H. 1993. Duchenne Muscular Dystrophy. Oxford Monographs on Medical Genetics. Oxford Univ. Press, Oxford.
  • Ervasti, J. M. & Campbell, K. P. 1993. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122, 809823.
  • Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E. & Mello, C. C. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806811.
  • Kawai, N., Tanaka, E., Langenbach, G. E., van Wessel, T., Brugman, P., Sano, R., van Eijden, T. M. & Tanne, K. 2007. Daily jaw muscle activity in freely moving rats measured with radio-telemetry. Eur. J. Oral Sci. 115, 1520.
  • Kawai, N., Tanaka, E., Langenbach, G. E., van Wessel, T., Sano, R., van Eijden, T. M. & Tanne, K. 2008. Jaw muscle activity changes after the induction of osteoarthrosis in the temporomandibular joint by mechanical loading. J. Orofac. Pain 22, 153162.
  • Kawai, N., Sano, R., Korfage, J. A., Nakamura, S., Kinouchi, N., Kawakami, E., Tanne, K., Langenbach, G. E. & Tanaka, E. 2010. Adaptation of rat jaw muscle fibers in postnatal development with a different food consistency: an immnohistochemical and EMG study. J. Anat. 216, 717723.
  • Kawakami, E., Kinouchi, N., Adachi, T., Ohsawa, Y., Ishimaru, N., Ohuchi, H., Sunada, Y., Hayashi, Y., Tanaka, E. & Noji, S. 2011. Atelocollagen-mediated systemic applications of myostatin-targeting siRNA improve the muscular atrophy of caveolin-3-deficient mice. Dev. Growth Differ. 53, 4854.
  • Kawakami, E., Kawai, N., Kinouchi, N., Mori, H., Ohsawa, Y., Ishimaru, N., Sunada, Y., Noji, S. & Tanaka, E. 2013. Local administrations of myostatin-siRNA with atelocollagen increase skeletal muscle mass and recovery of muscle function. PLoS ONE 8, e64719.
  • Kim, S., Garg, H., Joshi, A. & Manjunath, N. 2009. Strategies for targeted nonviral delivery of siRNAs in vitro. Trends Mol. Med. 15, 491500.
  • Kinouchi, N., Ohsawa, Y., Ishimaru, N., Ohuchi, H., Sunada, Y., Hayashi, Y., Tanimoto, Y., Moriyama, K. & Noji, S. 2008. Atelocollagen-mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass. Gene Ther. 15, 11261130.
  • Koenig, M., Monaco, A. P. & Kunkel, L. M. 1988. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53, 219228.
  • Korfage, J. A., Koolstra, J. H., Langenbach, G. E. & van Eijden, T. M. 2005. Fiber-type composition of the human jaw muscles–(part 1) origin and functional significance of fiber-type diversity. J. Dent. Res. 84, 774783.
  • Lares, M. R., Rossi, J. J. & Ouellet, D. L. 2011. RNAi and small interfering RNAs in human disease therapeutic applications. Trends Biotechnol. 28, 570579.
  • Lee, S. J. & McPherron, A. C. 2001. Regulation of myostatin activity and muscle growth. Proc. Natl Acad. Sci. USA 98, 93069311.
  • Lin, J., Arnold, H. B., Della-Fera, M. A., Azain, M. J., Hartzell, D. L. & Baile, C. 2002. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem. Biophys. Res. Commun. 291, 701706.
  • Maughan, R. J., Watson, J. S. & Weir, J. 1983. Strength and cross-sectional area of human skeletal muscle. J. Physiol. 338, 3749.
  • McCroskery, S., Thomas, M., Maxwell, L., Sharma, M. & Kambadur, R. 2003. Myostatin negatively regulates satellite cell activation and self-renewal. J. Cell Biol. 162, 11351147.
  • McFarlane, C., Hennebry, A., Thomas, M., Plummer, E., Ling, N., Sharma, M. & Kambadur, R. 2008. Myostatin signals through Pax7 to regulate satellite cell self-renewal. Exp. Cell Res. 314, 317329.
  • McPherron, A. C., Lawler, A. M. & Lee, S. J. 1997. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387, 8390.
  • Minakuchi, Y., Takeshita, F., Kosaka, N., Sasaki, H., Yamamoto, Y., Kouno, M., Honma, K., Nagahara, S., Hanai, K., Sano, A., Kato, T., Terada, M. & Ochiya, T. 2004. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Res. 32, e109.
  • Nishi, M., Yasue, A., Nishimatu, S., Nohno, T., Yamaoka, T., Itakura, M., Moriyama, K., Ohuchi, H. & Noji, S. 2002. A missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle. Biochem. Biophys. Res. Commun. 293, 247251.
  • Morel-Verdebout, C., Botteron, S. & Kiliaridis, S. 2007. Dentofacial characteristics of growing patients with Duchenne muscular dystrophy: a morphological study. Eur. J. Orthod. 29, 500507.
  • Ochiya, T., Nagahara, S., Sano, A., Itoh, H. & Terada, M. 2001. Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines. Curr. Gene Ther. 1, 3152.
  • Phalon, C., Rao, D. D. & Nemunaitis, J. 2010. Potential use of RNA interference in cancer therapy. Expert Rev. Mol. Med. 12, e26.
  • Sano, R., Tanaka, E., Korfage, J. A., Langenbach, G. E., Kawai, N., van Eijden, T. M. & Tanne, K. 2007. Heterogeneity of fiber characteristics in the rat masseter and digastric muscles. J. Anat. 211, 464470.
  • Simonds, A. K., Muntoni, F., Heather, S. & Fielding, S. 1998. Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy. Thorax 53, 949952.
  • Spagnou, S., Miller, A. & Keller, M. 2004. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry 43, 1334813356.
  • Stenzel, K. H., Miyata, T. & Rubin, A. L. 1974. Collagen as a biomaterial. Annu. Rev. Biophys. Bioeng. 3, 231253.
  • Tagami, T., Uehara, Y., Moriyoshi, N., Ishida, T. & Kiwada, H. 2011. Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of siRNA. J. Control. Release 154, 149154.
  • Tagami, T., Suzuki, T., Matsunaga, M., Nakamura, K., Moriyoshi, N., Ishida, T. & Kiwada, H. 2012. Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery. Int. J. Pharm. 422, 280289.
  • Takeshita, F., Minakuchi, Y., Nagahara, S., Honma, K., Sasaki, H., Hirai, K., Teratani, T., Namatame, N., Yamamoto, Y., Hanai, K., Kato, T., Sano, A. & Ochiya, T. 2005. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc. Natl Acad. Sci. USA 102, 1217712182.
  • Takeshita, F. & Ochiya, T. 2006. Therapeutic potential of RNA interference against cancer. Cancer Sci. 97, 689696.
  • Tiemann, K. & Rossi, J. J. 2009. RNAi-based therapeutics-current status, challenge and prospects. EMBO Mol. Med. 1, 142151.
  • Uezumi, A., Fukada, S., Yamamoto, N., Takeda, S. & Tsuchida, K. 2010. Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat. Cell Biol. 12, 143152.
  • van Wessel, T., Langenbach, G. E., Korfage, J. A., Brugman, P., Kawai, N., Tanaka, E. & van Eijden, T. M. 2005. Fiber type composition of rabbit jaw muscles is related to their daily activity. Eur. J. Neurosci. 22, 27832791.
  • Zhu, X., Hadhazy, M., Wehling, M., Tidball, J. G. & McNally, E. M. 2000. Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Lett. 474, 7175.